Aubagio (teriflunomide)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
CONTRAINDICATIONS
(addition) Patients with a history of a hypersensitivity reaction to teriflunomide, leflunomide, or to...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology